Hannah Maple, Petrut Gogalniceanu, Mira Zuchowski, Heather Draper, Lisa Burnapp, Paul McCrone, Joseph Chilcot, Sam Norton, Nizam Mamode
{"title":"Outcomes and motivations in Unspecified (non-directed altruistic) Kidney Donation: Results from a UK prospective cohort study.","authors":"Hannah Maple, Petrut Gogalniceanu, Mira Zuchowski, Heather Draper, Lisa Burnapp, Paul McCrone, Joseph Chilcot, Sam Norton, Nizam Mamode","doi":"10.1016/j.ajt.2025.03.021","DOIUrl":null,"url":null,"abstract":"<p><p>Unspecified kidney donors (UKDs) increase the number of high-quality kidneys available for transplantation. This study aimed to determine whether the practice was acceptable, based on non-inferiority of donor physical and psychosocial outcomes when compared to specified kidney donors (SKDs). A longitudinal, prospective cohort study investigated potential living kidney donors from across all 23 UK adult kidney transplant centres. Participants completed validated questionnaires at four time points (recruitment, 2-4 weeks pre-donation, 3- and 12-months post-donation). Clinical outcome data were collected from NHS Blood and Transplant. 373 (of 837 recruited; 45.7%) went on to donate (November 2016 - January 2021). There were no differences in donation rates (204 SKDs (54.7%) vs 169 UKDs (45.3%); p=0.944). Both groups reported being motivated by the desire to help someone (p=0.157). Tests for non-inferiority indicated that UKDs do no worse than SKDs on psychosocial or clinical outcomes over 12-months, and costs are similar (p>0.05). This is the world's largest prospective observational study comparing SKDs and UKDs. It has demonstrated no differences in primary motivation, donation rates, regret, cost, or psychosocial and physical outcomes. These data should reassure transplant professionals and potential donors and can bolster confidence in the practice around the world.</p>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":" ","pages":""},"PeriodicalIF":8.9000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajt.2025.03.021","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Unspecified kidney donors (UKDs) increase the number of high-quality kidneys available for transplantation. This study aimed to determine whether the practice was acceptable, based on non-inferiority of donor physical and psychosocial outcomes when compared to specified kidney donors (SKDs). A longitudinal, prospective cohort study investigated potential living kidney donors from across all 23 UK adult kidney transplant centres. Participants completed validated questionnaires at four time points (recruitment, 2-4 weeks pre-donation, 3- and 12-months post-donation). Clinical outcome data were collected from NHS Blood and Transplant. 373 (of 837 recruited; 45.7%) went on to donate (November 2016 - January 2021). There were no differences in donation rates (204 SKDs (54.7%) vs 169 UKDs (45.3%); p=0.944). Both groups reported being motivated by the desire to help someone (p=0.157). Tests for non-inferiority indicated that UKDs do no worse than SKDs on psychosocial or clinical outcomes over 12-months, and costs are similar (p>0.05). This is the world's largest prospective observational study comparing SKDs and UKDs. It has demonstrated no differences in primary motivation, donation rates, regret, cost, or psychosocial and physical outcomes. These data should reassure transplant professionals and potential donors and can bolster confidence in the practice around the world.
期刊介绍:
The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide.
The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.